About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Early Identification and Action in CKD

NCT02208674·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Geisinger Clinic

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

18 years of age or older
eGFRCR value between 45-59 ml/min/1.73m2 in the prior 12 months
scheduled laboratory appointment for serum creatinine testing within the next 30 days
average systolic or diastolic blood pressure reading of at least 150 or 85 mm Hg, respectively, during the prior 12 months.

You may not be if

fewer than 2 blood pressure readings in the prior 12 months,
pregnancy
current hospitalization
life expectancy less than 6 months as determined by the study investigators

The record

StatusCompleted

PhaseNo phase

Taking part47

StartedSep 2014

UpdatedNov 15, 2016

Conditions

Chronic Kidney Disease Hypertension

Where1

Geisinger Health System
Danville, Pennsylvania, United States

Clareo Health | Early Identification and Action in CKD